Mark Brosius Sells 648 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 648 shares of the company’s stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $495.20, for a total transaction of $320,889.60. Following the sale, the senior vice president directly owned 2,906 shares in the company, valued at $1,439,051.20. This trade represents a 18.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Mark Brosius also recently made the following trade(s):

• On Wednesday, March 4th, Mark Brosius sold 2,362 shares of Intuitive Surgical stock. The shares were sold at an average price of $498.68, for a total transaction of $1,177,882.16.
• On Tuesday, March 3rd, Mark Brosius sold 648 shares of Intuitive Surgical stock. The shares were sold at an average price of $488.10, for a total transaction of $316,288.80.
• On Monday, December 15th, Mark Brosius sold 464 shares of Intuitive Surgical stock. The stock was sold at an average price of $548.49, for a total transaction of $254,499.36.
• On Friday, December 12th, Mark Brosius sold 4,500 shares of Intuitive Surgical stock. The stock was sold at an average price of $547.36, for a total value of $2,463,120.00.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $490.16 on Friday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $603.88. The stock has a fifty day moving average of $521.64 and a 200 day moving average of $512.05. The firm has a market capitalization of $174.07 billion, a price-to-earnings ratio of 62.12, a P/E/G ratio of 3.83 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same period in the prior year, the company earned $2.21 EPS. The company’s quarterly revenue was up 18.8% compared to the same quarter last year. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Intuitive Surgical

A number of hedge funds have recently made changes to their positions in the business. Newbridge Financial Services Group Inc. lifted its stake in Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the last quarter. Holos Integrated Wealth LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth about $25,000. Tobam lifted its stake in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares during the last quarter. Kilter Group LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $27,000. Finally, Olistico Wealth LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at about $28,000. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on ISRG shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday, December 29th. UBS Group set a $570.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Tuesday, February 24th. TD Cowen raised shares of Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Citigroup reiterated a “neutral” rating and issued a $590.00 target price (down from $635.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Finally, Barclays set a $712.00 price target on Intuitive Surgical and gave the company an “overweight” rating in a research report on Monday, January 26th. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $615.86.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.